-
A randomised controlled feasibility study of a technology-assisted home-based aerobic exercise program for individuals with Parkinson’s disease
-
A Randomized Clinical Trial of Immersive Virtual Reality and Cognitive Rehabilitation for Mild Cognitive Impairment in Parkinson’s Disease
-
A Randomized, Double-blind Phase 3 Trial of Amlenetug Versus Placebo in Patients with MSA: The MASCOT Trial
-
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the NLRP3 Inhibitor Vent-02 in Patients with Mild to Moderate Parkinson’s Disease
-
A rapidly progressive multiple system atrophy-cerebellar variant model presentingα-synuclein oligomer spreading and phosphorylated α-synuclein aggregate formation accompanied with glial inflammation
-
A Rare Case of Anti-Hu Opsoclonus-Myoclonus Syndrome after Immune Checkpoint Inhibitor Immunotherapy in a Patient with Small Cell Lung Cancer in Remission
-
A Rare Case of Dipeptidyl-peptidase-like protein 6 (DPPX) Antibody-Associated Encephalitis
-
A Registry for Sleep and Circadian Health Quality in Parkinson’s Disease (ReSCQu-PD)
-
A Resting-State fMRI Study of Regional Homogeneity about Pain in Parkinson’s Disease
-
A retrospective analysis of an FMD IDC: considerations that impact outcomes.
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 181
- Next Page »